Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.40 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.40 |
| ▸ | HMBS | P08397 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.37 |
| ▸ | NQO2 | P16083 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL104381 | 0.78 | PTPN1 (0.34) | HMBSALDH1A1HPGDKMT2AMEN1 | |
| SCHEMBL12090766 | 0.75 | DAO (0.42) | HDAC4HDAC8GRIN2DGRIN3BGRIN1 | |
| SCHEMBL15764334 | 0.74 | BAZ2B (0.51) | ALDH1A1KMT2AGAAMEN1GLA | |
| SCHEMBL15764332 | 0.74 | CA12 (0.44) | ALDH1A1HPGDGAAGLANOTUM | |
| SCHEMBL18715211 | 0.74 | MAPT (0.40) | HDAC4HDAC8GRIN2DGRIN3BGRIN1 | |
| SCHEMBL2438835 | 0.73 | NPC1 (0.50) | HDAC8APPKMT2AMEN1POLB | |
| SCHEMBL11259706 | 0.71 | L3MBTL1 (0.46) | ALDH1A1HPGDGLANOTUMPOLB | |
| SCHEMBL19789312 | 0.71 | NQO2 (0.46) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL1627128 | 0.71 | NR4A2 (0.50) | ALDH1A1HPGDKMT2AGAAGLA | |
| SCHEMBL8404473 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388543-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-12-25 | — | — | US | disclosed |
| US-5399566-A | Hypotensive | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1995-03-21 | — | — | US | disclosed |
| EP-0487745-A1 | PYRIDINE DERIVATIVE WITH ANGIOTENSIN II ANTAGONISM | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1992-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388543-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | SCN8A, SCN1B, SCN3A | HDAC4 1595/4885HDAC8 252/4885GRIN2D 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.